Note: Ingredients listed on restricted chemical lists
General Information
Version
2.0
Revision date
2013-09-04
Product name
TERRAMYCIN
Chemical name
Mixture
1.2.1 Relevant identified uses
Veterinary product used as antibiotic agent
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Zoetis Inc
e-mail address of the competent person responsible for the Safety Data Sheet
VMIPSrecords@zoetis.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
SECTION 2: Hazards identification
Appearance Light yellow ointment Classification of the Substance or Mixture GHS - Classification Reproductive Toxicity: Category 1A EU Classification EU Indication of danger Toxic to reproduction: Category 1 EU Symbol T EU Risk Phrases R61 - May cause harm to the unborn child.
Signal word
Danger
Hazard statements
H360D - May damage the unborn child
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concemed: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations Sulfate Ophthalmic Ointment Updated: 04-Sep-2013 Version: 2.0
2.3 Other hazards
Long Term Repeat-dose studies in animals have shown a potential to cause adverse effects on male reproductive system, liver, the developing fetus. May cause effects similar to those seen in clinical use including transient diarrhea, nausea and abdominal pain. Symptoms of chronic exposure to tetracyclines include redness and swelling of the skin, rash, chills, tooth discoloration, yellowing of the skin and eyes, nausea, vomiting, diarrhea, stomach pain, and chest pain. Individuals sensitive to this material or other materials in its chemical class may develop allergic reactions. Wheezing, asthma, low or high blood pressure, dizziness, lung congestion, blood changes (leukocytosis, atypical lymphocytes, toxic granulation of granulocytes and thrombocytopenia purpura), convulsion or shock may also occur. Clinical use of this drug has caused liver effects, kidney dysfunction. Australian Hazard Classification (NOHSC)
Hazardous Ingredients
Non-Dangerous Goods Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
- Classification Reproductive Toxicity: Category 1A EU Classification: EU Indication of danger: Toxic to reproduction: Category 1 EU Symbol: T EU Risk Phrases: R61 - May cause harm to the unborn child. Label Elements